Iron chelation therapy in transfusion dependent patients with myelodysplastic syndrome with transfusional iron-overload in routine clinical management - interim analysis of the non-interventional study EXSEPT

被引：0
|
作者：
Nolte, F. [1 ]
Rubanov, O. [2 ]
Kuehn, R-B
Schumann, C. [1 ]
Kreil, S. [1 ]
Metzgeroth, G. [1 ]
Junkes, A. [3 ]
Johr, C. [3 ]
Albrecht, S. [3 ]
Hofmann, W-K [1 ]
机构：
[1] Univ Med Mannheim, Mannheim, Germany
[2] Off Based Hematol Oncol Specialist, Hamein, Germany
[3] Novartis Pharma GmbH, Nurnberg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P770
引用
收藏
页码：251 / 251
页数：1
相关论文
共 50 条
  • [31] Iron overload-related heart failure in a patient with transfusion-dependent myelodysplastic syndrome reversed by intensive combined chelation therapy
    Pinto, Valeria
    Balocco, Manuela
    Ambaglio, Ilaria
    Derchi, Giorgio
    Malcovati, Luca
    Forni, Gian Luca
    CLINICAL CASE REPORTS, 2015, 3 (11): : 952 - 954
  • [32] Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients
    Parisi, Sarah
    Finelli, Carlo
    JOURNAL OF BLOOD MEDICINE, 2021, 12 : 1019 - 1030
  • [33] Effect of availability of oral iron chelation therapy (ICT) on initiation, duration, and dose adequacy in patients with myelodysplastic syndromes (MDS) and transfusional iron overload (TIO).
    Gore, Steven
    Davidoff, Amy J.
    Hendrick, Franklin
    Vu Duong
    Stuart, Bruce C.
    Baer, Maria R.
    Shenolikar, Rahul
    Zeidan, Amer
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices
    Raptis, Anastasios
    Duh, Mei Sheng
    Wang, Si-Tien
    Dial, Ellison
    Fanourgiakis, Ilias
    Fortner, Barry
    Paley, Carole
    Mody-Patel, Nikita
    Corral, Mitra
    Scott, Jeffrey
    TRANSFUSION, 2010, 50 (01) : 190 - 199
  • [35] IRON CHELATION THERAPY IN TRANSFUSION-DEPENDENT MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE STUDY OF 53 PATIENTS IN A SINGLE INSTITUTION
    Finelli, C.
    Clissa, C.
    Barraco, M.
    De Maio, C.
    Fogli, M.
    Stanzani, M.
    Parisi, S.
    Paolini, S.
    Bosi, C.
    Cavo, M.
    HAEMATOLOGICA, 2017, 102 : 57 - 57
  • [36] Clinical Relevance of Individual Response to Iron Chelation Therapy (ICT) in Patients with Myelodysplastic Syndromes (MDS) and Transfusion Requirement
    Latagliata, Roberto
    Niscola, Pasquale
    Oliva, Esther Natalie
    Riva, Marta
    Capodanno, Isabella
    Volpe, Antonio
    Pilo, Federica
    Barate, Claudia
    Campagna, Alessia
    Pelizzari, Anna Maria
    Poloni, Antonella
    Sarlo, Chiara
    Mansueto, Giovanna
    Piccioni, Anna Lina
    Rosati, Serena
    Carmosino, Ida
    Carbone, Antonella
    Tognazzi, Lucia
    Salutari, Prassede
    Mancini, Annalisa
    Cuffari, Patrizia
    Pennese, Elsa
    Fenu, Susanna
    Spiriti, Maria Antonietta Aloe
    Galimberti, Sara
    Molteni, Alfredo
    Balleari, Enrico
    Breccia, Massimo
    Foa, Robin
    Maurillo, Luca
    Finelli, Carlo
    BLOOD, 2019, 134
  • [37] TREATMENT OF TRANSFUSIONAL IRON OVERLOAD IN PATIENTS WITH MYELODYSPLASTIC SYNDROME OR SEVERE ANEMIA: DATA FROM MULTI-CENTER CLINICAL PRACTICES
    Raptis, A.
    Duh, M. S.
    Wang, S. T.
    Dial, E.
    Fanourgiakis, I
    Fortner, B.
    Paley, C.
    Mody-Patel, N.
    Corral, M.
    Scott, J.
    VALUE IN HEALTH, 2009, 12 (03) : A132 - A132
  • [38] A Study to Assess and Improve Adherence to Iron Chelation Therapy in Transfusion-Dependent Thalassemia Patients
    Theppornpitak, Krisada
    Trakarnsanga, Bussaba
    Lauhasurayotin, Supanun
    Poparn, Hansamon
    Chiengthong, Kanhatai
    Sosothikul, Darintr
    Techavichit, Piti
    HEMOGLOBIN, 2021, 45 (03) : 171 - 174
  • [39] Updated recommendations on the management of gastrointestinal disturbances during iron chelation therapy with Deferasirox in transfusion dependent patients with myelodysplastic syndrome - Emphasis on optimized dosing schedules and new formulations
    Nolte, Florian
    Angelucci, Emanuele
    Breccia, Massimo
    Gattermann, Norbert
    Santini, Valeria
    Vey, Norbert
    Hofmann, Wolf-Karsten
    LEUKEMIA RESEARCH, 2015, 39 (10) : 1028 - 1033
  • [40] IRON CHELATION THERAPY IMPROVES OXIDATIVE DNA DAMAGE IN HEMATOPOIETIC CELLS DERIVED FROM TRANSFUSION-DEPENDENT MYELODYSPLASTIC SYNDROME
    Kobune, Masayoshi
    Kikuchi, Shohei
    Iyama, Satoshi
    Takada, Kohichi
    Murase, Kazuyuki
    Ono, Kaoru
    Horiguchi, Hiroto
    Kamihara, Yusuke
    Hayashi, Tsuyoshi
    Sato, Tsutomu
    Miyanishi, Koji
    Sato, Yasushi
    Takimoto, Rishu
    Kato, Junji
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (05) : E98 - E98
12345